20^th Asia Pacific Pathology Congress

About Conference

Conference series takes massive pleasure in inviting all the participants from across the globe to attend “20th Asia Pacific Pathology Congress” which will be held July 18-19, 2022 at Brisbane, Australia

Conference series organizing 1000+ international Events each year on Pharmaceutical Sciences, Clinical, Medicine, and Science & Technology once a year across USA, Europe, Asia, Middle East and United Kingdom with support from a thousand a lot of scientific societies and publishes 700+ open access journals that contains over one hundred thousand eminent scientific personalities, putative scientists as editorial board and organizing committee members.

Pathology is a topic that goes beyond medical guidelines of professionals. Pathology Congress 2022 puts together all the extroverts under one umbrella with current progress. Pathology is the general study of disease, incorporating a wide range of departments of biological science research and medical fields to describe work within the modern medical field of general pathology, which comprises the diagnosis of any specific disease generally over tissue, cell, and body fluid samples analysis. The pathology practitioner's physician is called a pathologist. Laboratory medicine is the medicine branch in which tissue, fluid or complex tissue examples are examined outside

Pathology Congress 2022 will exhibit the products and services from commercial and non-commercial organizations like Pathology Lab Equipment manufacturers, Clinical Trial Sites, Business delegates, lab equipment, Cell Diagnostics Laboratories, and Equipment Manufacturers.

We appreciate all interested participants to unite for our webinar on pathology congress.

Sessions/Tracks

Track 1: Pathology

Pathology is the study of the disease. It is the bridge between science and medicine. It supports all aspects of patient care, from diagnostic tests and treatment advice to the use of cutting-edge genetic technologies and disease prevention.

Physicians and scientists working with pathology are specialists in diseases and illnesses. They use their experience to support all aspects of health, from guiding doctors on how to treat common illnesses to using cutting-edge genetic technologies to treat patients with life-threatening conditions. Pathologists play a key role in research, advancing medicine and developing new treatments to fight viruses, infections and diseases like cancer.

Track 2: Hematopathology

Hematopathology is a comprehensive clinical and diagnostic division and provides specialized diagnostic and testing services for patients with all types of leukemia, myeloid neoplasia, lymphoma, myeloma and benign hematological diseases. We are specialized in the diagnosis of a variety of hematological disorders, including acute and chronic leukemia, myelodysplastic syndromes, myeloproliferative disorders, anemias and cytopenia, benign disorders of bone marrow and lymph nodes, B cell lymphomas and T cell lymphomas and cutaneous lymphomas.

The Hematopathology Division provides consultancy, laboratory testing and diagnosis, and coordinates specialized laboratories for molecular diagnosis, flow cytometry, cytogenetic and FISH analysis, and specialized bone marrow testing.

Track 3: Neuropathology

Neuropathology covers the study of diseases of the central nervous system (brain and spinal cord), peripheral and skeletal muscle. Neuropathologists spend most of their time diagnosing tumors, inflammatory diseases and infections.

Track 4: Cytopathology

The cytopathologist is an anatomical pathologist trained in the diagnosis of human diseases through the study of cells obtained from secretions and body fluids; scraping, washing or spongeing the surface of an injury; or by aspirating a tumor mass or organ from the body with a fine needle. Cytopathologists maintain a patient-centered approach by performing fine needle aspirations with assessment of suitability on site in collaboration with radiologists and primary care physicians.

Track 5: Digital pathology

Digital pathology is a subfield of pathology that focuses on data management based on information generated from digitized specimen slides. Through the use of computer-based technology, digital pathology practices virtual microscopy. Slides of glass are converted into digital slides that can be viewed, managed, shared and analyzed on a computer monitor. With the practice of Whole-Slide Imaging (WSI), which is another name for virtual microscopy, the field of digital pathology is growing and has applications in diagnostic medicine, with the objective of obtaining diagnoses, prognoses and disease prediction due to to success in Artificial Intelligence and Machine Learning 

Track 6: Histopathology

Histopathology is the study of the manifestations of the disease through microscopic examination of tissues from plants and animals. Histopathology focuses on the basic changes that happen in cells, tissues and organs when presented with harmful shocks. Histopathologists examine larger pieces of tissue to aid in the analysis and treatment of patients. It is performed by examining cells and tissues under a light microscope, which were sectioned, stained and mounted on a microscope slide.

Track 7: Psychopathology

Psychopathology, also called abnormal psychology, the study of mental disorders and unusual or maladaptive behaviors. An understanding of the genesis of mental disorders is critical for mental health professionals in psychiatry, psychology and social work. A controversial issue in psychopathology is the distinction between dysfunctional or aberrant and merely idiosyncratic behaviors.

Track 8: Pulmonary pathology

Pulmonary pathology is the subspecialty of surgical pathology that deals with the diagnosis and characterization of neoplastic and non-neoplastic diseases of the lungs and thoracic pleura. Diagnostic samples are often obtained by transbronchial bronchoscopic biopsy, CT-guided percutaneous biopsy or video-assisted thoracic surgery (VATS). The diagnosis of inflammatory or fibrotic diseases of the lungs is considered by many pathologists to be particularly challenging.

Track 9: Diagnostic Pathology

It is a branch that deals with the examination of the tissues of the body and their examination. Microscopic study of disease determination, abnormal tissue development, histopathology of the lesions and sometimes post-mortem. Conducts research on surgical pathology and in critical diagnosis.

Track 10: Neuropathology

Neuropathology is the study of diseases of the nervous system tissue, usually in the form of small surgical biopsies or autopsies of the whole body. Neuropathologists generally work in an anatomical pathology department, but work closely with the clinical disciplines of neurology and neurosurgery, which often depend on neuropathology for a diagnosis. Neuropathology is also related to forensic pathology, because brain disease or brain injury may be related to the cause of death.

Track 11: Renal Pathology

Renal biopsy is a valuable example. Its tiny size is misleading due to the enormous amount of data it contains, essential data to understand the etiology, treatment and prediction of the patient. Renal pathology or renal pathology covers the points of poisonous tubular rot, renal carcinomas, diabetic glomerulosclerosis and other diseases related to the kidneys inspected with an augmentation instrument or atomic test. Patients with kidney disease incorporate a wide range of restorative conditions that are occasionally complex and multisystemic in nature. 

Track 12: Surgical Pathology

Surgical Pathology Conferences are the investigation of tissues expelled from living patients during surgery to help analyze a disease and decide on a treatment schedule. Surgical pathology includes macroscopic and thorough examination of surgical examples and, in addition, biopsies gathered by specialists and non-specialist speech therapists conferences, for example, general internists, therapeutic subspecialists, dermatologists and interventional radiologists. The Division of Surgical Pathology is responsible for the histological analysis of biopsies and surgical resections of real organ structures.  

Track 13: Dermatopathology

Dermatopathology is a subspecialty of dermatology and pathology that includes the investigation of skin diseases at an infinitesimal level. Dermatopathology additionally involves examining the potential reasons for skin diseases. Histopathology conferences at a fundamental level. Skin biopsy is performed to obtain a definitive conclusion and inspected with a magnifying glass or subjected to other atomic tests.   

Track 14: Microbial Pathology

Microbial pathogenesis is the investigation of atomic systems used by organisms to cause disease in people and creatures. The Investigate Microbial Pathogenesis and Immunology division focuses on birthplace and improvement of human diseases with an emphasis on microbial specialists and subatomic instruments of host reaction and resilience. A wide variety of devices such as bacteria, protozoa, parasites and viral pathogens develop in the host and collect supplements, which also cause damage and disease. Microbiologists use each of the devices of current hereditary qualities, atomic science, biophysics and natural chemistry keeping in mind the ultimate goal of understanding the unpredictable procedure used by Microbial Pathology. Seeing how microorganisms cause disease is regularly the initial step towards improving new remediation methodologies.

Market Analysis

The pathology market is projected to reach a value of USD 44.4 billion by 2024 from USD 33.0 billion in 2019, at a CAGR of 6.1% from 2019 to 2024. The high incidence of cancer and other target diseases, availability of reimbursement, and the growing focus on personalized medicine are the major factors driving the growth of the pathology market.

Based on product & service, the pathology market is segmented into services, consumables, and instruments. The services segment accounted for the largest share of the anatomic pathology market in 2018. The large share of this segment can be attributed to the availability of reimbursements for diagnostic tests, rapid growth in the geriatric population, and the increasing incidence of cancer and other chronic diseases.

Based on end user, the pathology market is segmented into hospital laboratories, clinical laboratories, and other end users. In 2018, the hospital laboratories segment accounted for the largest market share and is expected to grow at the highest CAGR during the forecast period. The growth in this market can be attributed to the increasing number of patient visits to hospitals, growing number of in-house diagnostic procedures performed in hospitals, growing awareness regarding early disease diagnosis, and the availability of reimbursements in developed markets for clinical tests performed in hospitals.

By region, the anatomic pathology market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2018, North America accounted for the largest market share, followed by Europe. The rising prevalence of chronic diseases, increasing healthcare expenditure, the high-quality infrastructure for hospitals and clinical laboratories, and the presence of major market players in the region are driving the growth of the anatomic pathology market in North America.

The prominent players operating in the anatomic pathology market include F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), Thermo Fisher Scientific (US), Hologic, Inc. (US), Agilent Technologies (US), Becton, Dickinson and Company (US), Sakura Finetek (Japan), Merck KGaA (Germany), Bio SB (US), Diapath S.p.A. (Italy), and BioGenex Laboratories (US).

Digital Pathology Market:

The global digital pathology market is projected to be valued at $383.9 Million in 2016 and is expected to grow at a CAGR of 12.3% from 2017 to reach to $756.1 Million by 2022. Growth in the overall market is mainly driven by factors such as the growing applications of digital pathology in drug development and companion diagnostics, ease of consultation, increasing adoption of digital pathology to enhance lab efficiency, rising prevalence of cancer, and increasing initiatives by governments and industry players. Base year considered for the report is 2016 and the forecast period is 2017–2022.